Qiongfeng Wu
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Inhibition of transient receptor potential vanilloid 4: A promising novel strategy for myocardial ischemia/reperfusion injury treatment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 04, 2025
Transient receptor potential vanilloid 4 (TRPV4) in neutrophils enhances myocardial ischemia/reperfusion injury.
Journal: Journal of leukocyte biology
Published: October 24, 2022
Blockage of transient receptor potential vanilloid 4 prevents postoperative atrial fibrillation by inhibiting NLRP3-inflammasome in sterile pericarditis mice.
Journal: Cell calcium
Published: February 07, 2022
Interleukin-6-Mediated-Ca2+ Handling Abnormalities Contributes to Atrial Fibrillation in Sterile Pericarditis Rats.
Journal: Frontiers in immunology
Published: August 13, 2021
Activation of transient receptor potential vanilloid 4 exacerbates myocardial ischemia-reperfusion injury via JNK-CaMKII phosphorylation pathway in isolated mice hearts.
Journal: Cell calcium
Published: July 09, 2021
Identification of the distinctive role of DPT in dilated cardiomyopathy: a study based on bulk and single-cell transcriptomic analysis.
Journal: Annals of translational medicine
Published: June 06, 2021
Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 28, 2020
TRPV4 blockade suppresses atrial fibrillation in sterile pericarditis rats.
Journal: JCI insight
Published: February 24, 2020
Propofol Induces Cardioprotection Against Ischemia-Reperfusion Injury via Suppression of Transient Receptor Potential Vanilloid 4 Channel.
Journal: Frontiers in pharmacology
Published: April 21, 2019
Last Updated: 09/26/2026